Today we are happy to announce that we have entered into a co-marketing agreement with Thermo Fisher Scientific Inc, the world leader in serving science.
The new agreement aims to provide industry-leading data-independent acquisition (DIA) workflows through the combined use of Orbitrap mass spectrometers and Spectronaut software.
“We believe that deep proteome quantification with next-generation proteomics methods will become a keystone of modern biology. But we are aware that currently many researches are overwhelmed by the number of different methods out there and the wide range of skills required to get from sample to results. Our partnership with Thermo Fisher Scientific will enable us to provide better integrated solutions for DIA applications to our joint customers that help them to fully exploit the potential of proteomics for their research,” said Oliver Rinner, CEO of Biognosys AG.
More information about the co-marketing agreement are available in the press release (click for download).